Healthcare provider profile · identity verified

Julia Blake Allen Shaw

Nurse Practitioner · LUMBERTON, NC · NPI 1841863560

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	309	72
Gabapentin	Gabapentin	268	44
Amlodipine Besylate	Amlodipine Besylate	266	53
Rosuvastatin Calcium	Rosuvastatin Calcium	211	42
Albuterol Sulfate Hfa	Albuterol Sulfate	192	41
Lisinopril	Lisinopril	190	42
Losartan Potassium	Losartan Potassium	187	42
Levothyroxine Sodium	Levothyroxine Sodium	176	36
Metoprolol Succinate	Metoprolol Succinate	171	35
Pantoprazole Sodium	Pantoprazole Sodium	160	33
Potassium Chloride	Potassium Chloride	160	29
Furosemide	Furosemide	151	27
Omeprazole	Omeprazole	147	34
Trazodone Hcl	Trazodone Hcl	142	22
Hydrochlorothiazide	Hydrochlorothiazide	135	33
Metformin Hcl	Metformin Hcl	133	24
Metformin Hcl Er	Metformin Hcl	125	26
Fluticasone Propionate	Fluticasone Propionate	121	30
Alprazolam	Alprazolam	116	18
Clopidogrel	Clopidogrel Bisulfate	97	22
Metoprolol Tartrate	Metoprolol Tartrate	96	18
Montelukast Sodium	Montelukast Sodium	96	19
Simvastatin	Simvastatin	93	18
Meloxicam	Meloxicam	89	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	79	18
Oxycodone Hcl	Oxycodone Hcl	79	suppressed
Carvedilol	Carvedilol	75	16
Eliquis	Apixaban	75	18
Sertraline Hcl	Sertraline Hcl	75	16
Tamsulosin Hcl	Tamsulosin Hcl	75	20
Ozempic	Semaglutide	72	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	71	22
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	67	11
Ezetimibe	Ezetimibe	64	16
Zolpidem Tartrate	Zolpidem Tartrate	63	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	61	suppressed
Glipizide Er	Glipizide	59	14
Jardiance	Empagliflozin	56	suppressed
Prednisone	Prednisone	56	39
Spironolactone	Spironolactone	55	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	53	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	52	11
Pregabalin	Pregabalin	51	suppressed
Lorazepam	Lorazepam	50	suppressed
Ropinirole Hcl	Ropinirole Hcl	49	11
Duloxetine Hcl	Duloxetine Hcl	45	suppressed
Ibuprofen	Ibuprofen	45	16
Azithromycin	Azithromycin	43	42
Methocarbamol	Methocarbamol	43	18
Pravastatin Sodium	Pravastatin Sodium	42	12
Venlafaxine Hcl Er	Venlafaxine Hcl	41	suppressed
Aripiprazole	Aripiprazole	39	suppressed
Citalopram Hbr	Citalopram Hydrobromide	39	suppressed
Mirtazapine	Mirtazapine	39	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	38	suppressed
Hydralazine Hcl	Hydralazine Hcl	37	suppressed
Promethazine Hcl	Promethazine Hcl	37	11
Buspirone Hcl	Buspirone Hcl	34	11
Paroxetine Hcl	Paroxetine Hcl	34	suppressed
Glipizide	Glipizide	33	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	32	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	31	suppressed
Allopurinol	Allopurinol	31	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	31	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	31	11
Nitroglycerin	Nitroglycerin	31	suppressed
Synthroid	Levothyroxine Sodium	31	suppressed
Clonazepam	Clonazepam	30	suppressed
Atenolol	Atenolol	29	suppressed
Diclofenac Sodium	Diclofenac Sodium	29	suppressed
Xarelto	Rivaroxaban	28	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	27	suppressed
Symbicort	Budesonide/Formoterol Fumarate	27	suppressed
Fluconazole	Fluconazole	26	14
Celecoxib	Celecoxib	25	suppressed
Mounjaro	Tirzepatide	25	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	25	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	24	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	24	suppressed
Diazepam	Diazepam	23	suppressed
Solifenacin Succinate	Solifenacin Succinate	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	22	11
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Methylprednisolone	Methylprednisolone	22	22
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	20
Tramadol Hcl	Tramadol Hcl	22	suppressed
Pen Needles	Pen Needle, Diabetic	21	suppressed
Temazepam	Temazepam	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	18
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Naproxen	Naproxen	20	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	suppressed
Rybelsus	Semaglutide	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Rizatriptan	Rizatriptan Benzoate	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Estradiol	Estradiol	17	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Ibu	Ibuprofen	17	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Olanzapine	Olanzapine	17	suppressed
Ramipril	Ramipril	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	16
Amiodarone Hcl	Amiodarone Hcl	16	suppressed
Baclofen	Baclofen	16	suppressed
Linzess	Linaclotide	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Ranolazine Er	Ranolazine	15	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Potassium Citrate Er	Potassium Citrate	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Alendronate Sodium	Alendronate Sodium	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Cephalexin	Cephalexin	13	11
Fentanyl	Fentanyl	13	suppressed
Lubiprostone	Lubiprostone	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	12	suppressed
Cholestyramine Light	Cholestyramine	12	suppressed
Digoxin	Digoxin	12	suppressed
Dofetilide	Dofetilide	12	suppressed
Febuxostat	Febuxostat	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Mesalamine Er	Mesalamine	12	suppressed
Naloxone Hcl	Naloxone Hcl	12	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Perindopril Erbumine	Perindopril Erbumine	12	suppressed
Prempro	Estrogen,con/M-Progest Acet	12	suppressed
Pure Comfort Alcohol Pad	Alcohol Antiseptic Pads	12	suppressed
Risperidone	Risperidone	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Clindamycin Hcl	Clindamycin Hcl	11	11
Dayvigo	Lemborexant	11	suppressed
Dexamethasone	Dexamethasone	11	11
Farxiga	Dapagliflozin Propanediol	11	suppressed
Finasteride	Finasteride	11	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error